Johanna E. Emmens

606 total citations
16 papers, 245 citations indexed

About

Johanna E. Emmens is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Johanna E. Emmens has authored 16 papers receiving a total of 245 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 3 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in Johanna E. Emmens's work include Heart Failure Treatment and Management (10 papers), Diabetes Treatment and Management (3 papers) and Neuropeptides and Animal Physiology (3 papers). Johanna E. Emmens is often cited by papers focused on Heart Failure Treatment and Management (10 papers), Diabetes Treatment and Management (3 papers) and Neuropeptides and Animal Physiology (3 papers). Johanna E. Emmens collaborates with scholars based in Netherlands, United Kingdom and Italy. Johanna E. Emmens's co-authors include Adriaan A. Voors, Marco Metra, Dirk J. van Veldhuisen, Jozine M. ter Maaten, John G.F. Cleland, Kevin Damman, Beth A. Davison, Leong L. Ng, Gad Cotter and Rudolf A. de Boer and has published in prestigious journals such as European Heart Journal, Clinical Journal of the American Society of Nephrology and European Journal of Heart Failure.

In The Last Decade

Johanna E. Emmens

14 papers receiving 243 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Johanna E. Emmens Netherlands 9 147 58 48 47 40 16 245
Mehmet Oezkur Germany 9 164 1.1× 85 1.5× 18 0.4× 83 1.8× 87 2.2× 31 319
Olga Cuccurullo Italy 3 353 2.4× 18 0.3× 69 1.4× 39 0.8× 26 0.7× 6 420
Tushar Acharya United States 11 212 1.4× 13 0.2× 51 1.1× 72 1.5× 36 0.9× 30 332
Wendy McCallum United States 10 186 1.3× 90 1.6× 47 1.0× 38 0.8× 80 2.0× 31 272
Zaid Sabti Switzerland 9 241 1.6× 47 0.8× 8 0.2× 51 1.1× 60 1.5× 15 297
Julian Westphal Germany 9 248 1.7× 16 0.3× 100 2.1× 60 1.3× 78 1.9× 26 344
Giovanni Peretto Italy 5 177 1.2× 41 0.7× 29 0.6× 80 1.7× 16 0.4× 6 263
Santhosh Jay Mathews United States 8 160 1.1× 38 0.7× 47 1.0× 98 2.1× 65 1.6× 14 300
Yoshihiro Matsumoto Japan 8 125 0.9× 147 2.5× 109 2.3× 56 1.2× 84 2.1× 17 328
Alberto Preda Italy 8 133 0.9× 12 0.2× 45 0.9× 40 0.9× 33 0.8× 40 289

Countries citing papers authored by Johanna E. Emmens

Since Specialization
Citations

This map shows the geographic impact of Johanna E. Emmens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johanna E. Emmens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johanna E. Emmens more than expected).

Fields of papers citing papers by Johanna E. Emmens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johanna E. Emmens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johanna E. Emmens. The network helps show where Johanna E. Emmens may publish in the future.

Co-authorship network of co-authors of Johanna E. Emmens

This figure shows the co-authorship network connecting the top 25 collaborators of Johanna E. Emmens. A scholar is included among the top collaborators of Johanna E. Emmens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johanna E. Emmens. Johanna E. Emmens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Emmens, Johanna E., Jasper Tromp, Marcelle D. Smit, et al.. (2025). Association Between Antecedent Myocardial Infarction and Heart Failure with Preserved Versus Reduced Ejection Fraction. European Journal of Heart Failure. 27(12). 2918–2920.
2.
Emmens, Johanna E., Jasper Tromp, Wouter Ouwerkerk, et al.. (2024). Sex-specific risk factors for new-onset heart failure: the PREVEND study at 25 years. European Heart Journal. 46(16). 1528–1536. 13 indexed citations
3.
Emmens, Johanna E., Arno R. Bourgonje, Solmaz Assa, et al.. (2023). Systemic oxidative stress associates with disease severity and outcome in patients with new-onset or worsening heart failure. Clinical Research in Cardiology. 112(8). 1056–1066. 7 indexed citations
4.
Boorsma, Eva M., Johanna E. Emmens, Marco Metra, et al.. (2023). Biomarker Signature and Pathophysiological Pathways in Patients with Chronic Heart Failure and Metabolic Syndrome. European Journal of Heart Failure. 25(2). 163–173. 7 indexed citations
5.
Emmens, Johanna E., Martin H. de Borst, Eva M. Boorsma, et al.. (2022). Assessment of Proximal Tubular Function by Tubular Maximum Phosphate Reabsorption Capacity in Heart Failure. Clinical Journal of the American Society of Nephrology. 17(2). 228–239. 9 indexed citations
6.
Boorsma, Eva M., Jozine M. ter Maaten, Kevin Damman, et al.. (2022). Albuminuria as a marker of systemic congestion in patients with heart failure. European Heart Journal. 44(5). 368–380. 39 indexed citations
7.
Emmens, Johanna E., Stijn de Vos, Jens Bos, et al.. (2022). Sex disparities in the effect of statins on lipid parameters: The PharmLines Initiative. Utrecht University Repository (Utrecht University). 14 indexed citations
8.
Boorsma, Eva M., et al.. (2022). Biomarker profiles and pathophysiological pathways in patients with chronic heart failure and metabolic syndrome. European Heart Journal. 43(Supplement_2).
9.
Emmens, Johanna E., Jozine M. ter Maaten, Yuya Matsue, et al.. (2021). Worsening renal function in acute heart failure in the context of diuretic response. European Journal of Heart Failure. 24(2). 365–374. 41 indexed citations
10.
Emmens, Johanna E., Jozine M. ter Maaten, Frank P. Brouwers, et al.. (2021). Proenkephalin and the risk of new‐onset heart failure: data from prevention of renal and vascular end‐stage disease. Clinical Cardiology. 44(12). 1662–1672. 4 indexed citations
11.
Emmens, Johanna E., Leong L. Ng, Dirk J. van Veldhuisen, et al.. (2021). Impaired High‐Density Lipoprotein Function in Patients With Heart Failure. Journal of the American Heart Association. 10(9). e019123–e019123. 13 indexed citations
13.
Emmens, Johanna E., et al.. (2020). Impaired high-density lipoprotein function in patients with heart failure. European Heart Journal. 41(Supplement_2). 2 indexed citations
14.
Maaten, Jozine M. ter, Johanna E. Emmens, Joachim Struck, et al.. (2019). Clinical Value of Pre-Discharge Bio-Adrenomedullin as a Marker of Residual Congestion and High Risk of Heart Failure Hospital Readmission. European Journal of Heart Failure. 22(4). 683–691. 35 indexed citations
15.
Emmens, Johanna E., Jozine M. ter Maaten, Kevin Damman, et al.. (2019). Proenkephalin, an Opioid System Surrogate, as a Novel Comprehensive Renal Marker in Heart Failure. Circulation Heart Failure. 12(5). e005544–e005544. 26 indexed citations
16.
Emmens, Johanna E., Jozine M. ter Maaten, Yuya Matsue, et al.. (2015). Plasma Kidney Injury Molecule-1 in Heart Failure: Renal Mechanisms and Clinical Outcome. European Journal of Heart Failure. 18(6). 641–649. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026